Browsing: Mortality Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for mortality risk analysis, commentary and insights.
Life Risk News Q&A: Cobus Daneel, Chair, Continuous Mortality Investigation Projections Committee, shares what is top of mind in the mortality actuarial world as we look ahead to 2025.
Farsight Partners has finalised an agreement with funds managed by AB CarVal to source and advise on up to $1bn of transactions.
New research suggests that the chances then that the next 100 years or so brings about a similar jump?
It could take decades for the new legislation to have any discernible impact on mortality.
Life Risk News’ latest roundtable digs deep into the current state of ESG as it pertains to the life risk industry.
While ageing is fundamentally a physiological phenomenon, numerous factors significantly influence the rate at which this process occurs. Certain factors can accelerate the ageing process, while some have the potential to decelerate it, influencing the rate of physiological decline.
New technological advances to meet key healthcare needs are a crucial element driving the performance profile of the healthcare sector.
Private equity-backed reinsurers’ appetite for Asian life insurance assets is unlikely to be sated any time soon, as there is $2 trillion of assets/liabilities under management that are currently providing sub-par capital returns
US life expectancy gap to other developed countries has widened in the past two years.
Equity Release mortgage securitisations carry a range of benefits for institutional investors when compared to standard residential mortgage-backed securities (RMBS). …